Griffiths A N, Jones D M, Richens A
Br J Clin Pharmacol. 1986 Jun;21(6):647-53. doi: 10.1111/j.1365-2125.1986.tb05229.x.
The cognitive function and psychomotor performance of 10 healthy male volunteers were measured following single oral doses of: zopiclone (7.5 mg), flurazepam (15 mg), lormetazepam (1 mg), triazolam (0.25 mg) and placebo. The performance tests selected (stroop task, five choice serial reaction time, memory span, logical reasoning, mood and saccadic eye movement analysis) were thought to reflect aspects of normal daily activity. The tests demonstrated a clear reduction of performance for all active treatments. No drug emerged as the most potent sedative overall, as each of the tests was affected to a different degree by each drug. Drug effects were not qualitatively different between active treatments so that zopiclone was indistinguishable from the three benzodiazepines with which it was compared.
对10名健康男性志愿者单次口服以下药物后,测量其认知功能和精神运动表现:佐匹克隆(7.5毫克)、氟西泮(15毫克)、氯美扎酮(1毫克)、三唑仑(0.25毫克)和安慰剂。所选择的表现测试(斯特鲁普任务、五选择连续反应时、记忆广度、逻辑推理、情绪和眼跳运动分析)被认为能反映正常日常活动的各个方面。测试表明,所有活性药物治疗后表现均明显下降。没有一种药物被证明是总体上最有效的镇静剂,因为每种测试受每种药物的影响程度不同。活性药物治疗之间的药物效果在质量上没有差异,因此佐匹克隆与与之比较的三种苯二氮䓬类药物没有区别。